The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic

Daniele Napolitano, Linda Galasso, Giuseppe Privitera, Giuseppe Morana, Arianna Bardelli, Rita Sinatora, Maria Francesca Onidi, Maria Teresa Lombardi, Nicoletta Orgiana, Valeria Amatucci, Martina Strazzeri, Elisa Schiavoni, Laura Turchini, Alessandra Guarini, Antonella Guarini, Carlo Romano Settanni, Alessandro Armuzzi, Franco Scaldaferri

Risultato della ricerca: Contributo in rivistaArticolo in rivista


Background: During the COVID-19 pandemic, many inflammatory bowel disease (IBD) centres had to reorganise their work, and multidisciplinary teams, including IBD nurses, have had to try to deliver services to patients as safely as possible. Aims: This survey aimed to assess the thoughts, opinions and feelings of IBD patients on biologics regarding the efforts of IBD nurses to organise care during the COVID-19 pandemic. Methods: An evaluation survey based on an anonymous questionnaire was distributed to IBD nurses in five Italian IBD centres, in parallel. Findings: Of 306 participants, 55.6% had Crohn’s disease and 44.4% had ulcerative colitis. Most (79.1%) were aware of the specialist IBD nurse role, and 75.8% could distinguish it from generalist nurses. Of patients, 99.7% felt IBD nurses were competent to care for their condition and 91.2% felt that IBD nurses could provide valid scientific information. Meanwhile, 81.4% had a good or excellent relationship with their IBD nurse. Patients reported that most nurses wore personal protective equipment (94.4%), promoted self-care (91.8%), asked about presence of fever or cough (84.3%), asked about patient health status (83.7%) and covered pandemic safety and social distancing rules (69.3%), but fewer spoke about patient mood (44.4%) or relevant benefits, rules and exemptions (26.8%). Most participants (77.8%) faced pandemic-related issues for infusions. Nearly all (97.4%) knew immunosuppressed people were vulnerable to COVID-19, but only 42.8% spoke to their nurse about it. Some 61.8% of patients were concerned about COVID-19, but only 39.2% raised this with the IBD nurse. However, many more patients spoke to a nurse about concerns regarding biologics (41.8%) and worsening IBD symptoms (46.4%) in the pandemic than the actual number experiencing these issues (13.7% and 4.3%, respectively). Conclusion: The results show that IBD patients appreciate the role of the specialist nurse in their care.
Lingua originaleEnglish
pagine (da-a)40-46
Numero di pagine7
RivistaGastrointestinal Nursing
Stato di pubblicazionePubblicato - 2022


  • biologic therapy


Entra nei temi di ricerca di 'The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic'. Insieme formano una fingerprint unica.

Cita questo